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removed by lesser resections. Lesser resections appar-
ently have an anatomic advantage over lobectomy.
However, it is unclear whether the functional advantage
of lesser resections is as great as the anatomic advan-
tage over lobectomy.
Several authors have noted that local recurrence is
more prevalent after lesser resections than after lobec-
tomy.1-3,5 Is the functional benefit of lesser resections
great enough for patients to risk having a local recur-
rence if they can tolerate a lobectomy? The aim of this
study is to compare pulmonary function after segmen-
tectomy with that after lobectomy in patients with small
peripheral carcinoma of the lung. 
Patients and methods 
Segmentectomy. The study was conducted between
January 1993 and December 1996 with the approval of our
institutional ethics board. We performed segmentectomies on
patients who had a small peripheral tumor and who were
T he extent of resection has been discussed for smallperipheral carcinoma of the lung, because these
tumors are regarded as possibly being amenable to less-
er resections (segmentectomy and wedge resection)
than lobectomy. Although survival, recurrence, mortali-
ty, and morbidity after lesser resections have been
investigated in several studies,1-6 postoperative pul-
monary function has been evaluated only rarely.5 Some
lobar segments that are removed by a lobectomy are not
Objective: The aim of this study is to compare the pulmonary function
after a segmentectomy with that after a lobectomy for small peripheral
carcinoma of the lung. Patients and methods: Between 1993 and 1996, seg-
mentectomy and lobectomy were performed on 48 and 133 good-risk
patients, respectively. Lymph node metastases were detected after the
operation in 6 and 24 patients of the segmentectomy and lobectomy
groups, respectively. For bias reduction in comparison with a nonran-
domized control group, we paired 40 segmentectomy patients with 40
lobectomy patients using nearest available matching method on the esti-
mated propensity score. Results: Twelve months after the operation, the
segmentectomy and lobectomy groups had forced vital capacities of 2.67
± 0.73 L (mean ± standard deviation) and 2.57 ± 0.59 L, which were cal-
culated to be 94.9% ± 10.6% and 91.0% ± 13.2% of the preoperative
values (P = .14), respectively. The segmentectomy and lobectomy groups
had postoperative 1-second forced expiratory volumes of 1.99 ± 0.63 L
and 1.95 ± 0.49 L, which were calculated to be 93.3% ± 10.3% and
87.3% ± 14.0% of the preoperative values, respectively (P = .03). The
multiple linear regression analysis showed that the alternative of seg-
mentectomy or lobectomy was not a determinant for postoperative
forced vital capacity but did affect postoperative 1-second forced expi-
ratory volume. Conclusion: Pulmonary function after a segmentectomy
for a good-risk patient is slightly better than that after a lobectomy.
However, segmentectomy should be still the surgical procedure for only
poor-risk patients because of the difficulty in excluding patients with
metastatic lymph nodes from the candidates for the procedure.
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believed able to tolerate a lobectomy, so long as no nodal
metastases were identified during the operation. The choice
of the operation was left to the discretion of the surgeon. In
each segmentectomy, the pulmonary artery, pulmonary vein,
and segmental bronchus were isolated. After the vessels were
divided, the lobe was inflated and the segmental bronchus
was closed to trap the air in the segment. We thereafter resect-
ed this segment, which remained inflated, whereas the other
lobar parenchyma became deflated within several minutes.
The intersegmental plane was not stripped. We always used a
surgical stapler to divide the intersegmental planes. Two seg-
ments were removed when the tumor was localized beyond
the segment or when bi-segmentectomy was easier than seg-
mentectomy. Systematic hilar and mediastinal lymphadenec-
tomy were done as previously described.7 If necessary, a few
lymph nodes were sampled during the operation and exam-
ined pathologically to determine whether they contained
tumor metastasis. When the sampled node was metastatic, we
converted the segmentectomy to a lobectomy during the
operation.
Patients. During the period, 184 good-risk patients had
peripheral non–small cell lung cancer, in which the stage
appeared to be T1 N0 intraoperatively; these patients were
eligible for this study (Fig 1). Patients were excluded when
they had a tumor in the right middle lobe. The alternative
choice in the 2 operative procedures was left to the discretion
Fig 1. Patients eligible for the comparative study of postoperative pulmonary function. NSCLC, Non–small cell
lung cancer.
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of the surgeon. Lobectomies were performed in 133 patients.
Segmentectomies were intended for 51 good-risk patients.
Three segmentectomies were converted to lobectomies
because metastatic lymph nodes were identified during the
operation. Lymph node metastases were revealed after the
operation in 24 and 6 patients of the lobectomy and segmen-
tectomy groups, respectively. Of the 6 patients with metasta-
tic lymph nodes in the segmentectomy group, 4 had N1 dis-
ease and 2 had N2 disease. One patient underwent a
completion lobectomy. Two patients underwent adjuvant irra-
diations. Three patients had no adjuvant therapy. Post-
operative pulmonary function testing was scheduled for 109
and 42 patients who had a pathologic T1 N0 tumor resected
by lobectomy and segmentectomy, respectively. For 101 and
40 patients who underwent lobectomy and segmentectomy,
the testing was done 2 weeks and 12 months after the opera-
tion. The testing was not done in 10 patients because of
refusal in 2 patients, postoperative persistent air leakage in 4
patients, and diseases that developed in the postoperative
period in 4 patients: cancer recurrence in 2 patients, gastric
cancer in 1 patient, and depression in 1 patient. One patient
who was eligible for this study died in the perioperative peri-
od. This patient had nodal metastases resected by lobectomy.
Pulmonary function testing. Pulmonary function was
tested with a spirometer (Chestac-55V, Chest M. I. Inc,
Japan) according to American Thoracic Society standards.8
The forced vital capacity (FVC) and the 1-second forced
expiratory volume (FEV1) were measured in all patients. The
measurements were documented in the form of the actual vol-
ume and the ratio of the actual volume to the standard volume
that is determined by age, sex, and height of a patient accord-
ing to Baldwin’s formula for FVC and Berglund’s formula for
FEV1.9,10 To compare the actual postoperative pulmonary
function with the predicted function, we calculated the pre-
dicted postoperative pulmonary function according to the
formula described in an earlier study.11 In brief, the calcula-
tion was based on the number of segments that remained
after the operation. The lower lobes were considered to have
5 pulmonary segments each, the right upper lobe had 3 seg-
ments, and the left upper lobe had 4 segments. Each segment
was supposed to represent 1⁄19 or 0.0526 of the preoperative
function.
Statistical analysis. To reduce the bias in the comparison
of a nonrandomized control group, we paired the segmentec-
tomy group with the lobectomy group using the nearest avail-
able matching method on the estimated propensity score.12 To
compare the frequencies of the categoric data in the 2 groups,
we used the c 2 tests with Yates’ correction for continuity. To
compare the distribution of tumor size, number of resected
segments, and spirometric values in the 2 groups, we used the
2-sample t test. To compare the distribution of the actual post-
operative pulmonary function with the predicted function, we
used the paired t test. To examine determinants for postoper-
ative pulmonary function, we used multiple linear regression.
All statistical analyses were performed with the SPSS soft-
ware package (SPSS Inc, Chicago, Ill).
Table I. Segmentectomy and lobectomy groups paired
by nearest available matching method on the estimated
propensity score
Variables Segmentectomy Lobectomy P value
No. 40 40
Male/female 22/18 21/19 .8
Age (y) 65.0 ± 6.4 64.0 ± 7.3 .5
Tumor
Histology
Squamous cell 6 9 .6
Adenocarcinoma 33 30
Others 1 1
Size (cm) 1.7 ± 0.4 1.9 ± 0.5 .08
Location
Right upper lobe 11 15 .7
Right lower lobe 6 6
Left upper lobe 14 13
Left lower lobe 9 6
Pulmonary function
FVC
Liters 2.81 ± 0.70 2.85 ± 0.63 .8
% of std. 101.4 ± 16.5 102.0 ± 13.1 .9
FEV1
Liters 2.13 ± 0.61 2.25 ± 0.63 .3
% of std. 105.0 ± 24.6 109.4 ± 18.3 .4
Logit of the 1.12 ± 0.58 1.17 ± 0.55 .7
propensity score
FVC, Forced vital capacity; FEV1, 1-second forced expiratory volume; % of
std., the ratio of actual volume to standard volume that is determined by age,
sex, and height of the patient according to Baldwin’s formula for FVC and
Berglund’s formula for FEV1. The distribution is represented by the mean
value ± standard deviation.
Table II. The distribution of resected segments in the
segmentectomy group
Resected No. of 
Tumor location No. segment(s) patients
Right upper lobe 11 Apical 2 
Anterior 4
Posterior 3
Apicoposterior 2
(bi-segmentectomy)
Right lower lobe 6 Superior (apical) 3
Anterior basal 1
Apicoposterior basal 1
(bi-segmentectomy)
Anterolateral basal 1
(bi-segmentectomy)
Left upper lobe 14 Apicoposterior 1
Anterior 1
Superior-inferior lingula 4
(bi-segmentectomy)
Superior division 8
(bi-segmentectomy)
Left lower lobe 9 Superior (apical) 8
Anterior basal 1
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Results 
Table I shows the characteristics of segmentectomy
and lobectomy groups paired by nearest available
matching method on the estimated propensity score.
Tumor size in the original lobectomy group was 2.2 ±
0.5 cm (mean ± standard deviation), significantly larg-
er than that in the segmentectomy group (P < .01). The
distribution of tumor types and locations was also dif-
ferent between the 2 groups, although the difference
was not statistically significant. Logit of the propensity
score was 1.53 ± 0.55 for the original lobectomy group,
significantly different from that for the segmentectomy
group (P < .01). As shown in Table I, no significant dif-
ference between the 2 groups was observed in the cate-
goric and sequential variables including logit of the
propensity score after matching. 
Table II shows the distribution of resected segments
in the segmentectomy group. The nomenclature of
bronchopulmonary segments was used according to the
textbook Thoracic and Cardiovascular Surgery.13 A-
segmentectomy and bi-segmentectomy were performed
for 24 and 16 patients, respectively. 
Table III demonstrates the number of resected seg-
ments, the predicted FEV1, and the postoperative FVC
and FEV1. The number of resected segments was sig-
nificantly different between the 2 groups, as was the
predicted FEV1. Two weeks after the operation, the
FVC was slightly higher in the segmentectomy group
than in the lobectomy group. A statistically significant
difference was observed between the 2 groups in the
ratio of postoperative to preoperative FVC (P = .03),
although the actual FVC and the percent of the stan-
dard FVC were not significantly different between the
2 groups. At 12 months, no significant difference was
shown between the 2 groups in the actual FVC, the per-
cent of the standard FVC, and the ratio of postoperative
to preoperative FVC. 
Both 2 weeks and 12 months after the operation, a
statistically significant difference was observed
between the 2 groups in the ratio of postoperative to
preoperative FEV1 (P = .03), although the actual FEV1
and the percent of standard FEV1 were not significant-
ly different between the 2 groups. At 12 months, the
lobectomy group had a significantly higher FEV1 than
the predicted FEV1 (paired t test, P < .01), whereas the
segmentectomy group had almost the same FEV1 as the
predicted value.
Table IV shows the results of multiple linear regres-
sion analysis for determinants of postoperative pul-
monary function at 12 months. FVC and FEV1 were
represented by the ratio of the actual volume to the
standard volume. Correlation coefficients of the model
were 0.74 (P < .01) and 0.82 (P < .01) for FVC and
FEV1, respectively. An increase in 1% of the preopera-
Table III. Postoperative pulmonary function 
Segmentectomy Lobectomy P value
No. 40 40
No. of resected segments 1.4 ± 0.5 3.9 ± 0.8 <.01
Predicted FEV1
% of pre. 92.8 ± 2.5 79.3 ± 4.4 <.01
FVC
Two weeks
Liters 2.05 ± 0.66 1.91 ± 0.51 .3
% of std. 71.9 ± 19.7 67.4 ± 10.0 .2
% of pre. 72.7 ± 12.5 67.2 ± 9.7 .03
Twelve months
Liters 2.67 ± 0.73 2.57 ± 0.59 .5
% of std. 95.3 ± 20.0 92.4 ± 16.7 .5
% of pre. 94.9 ± 10.6 91.0 ± 13.2 .14
FEV1
Two weeks
Liters 1.54 ± 0.51 1.50 ± 0.44 .7
% of std. 75.5 ± 22.3 73.3 ± 16.4 .6
% of pre. 73.0 ± 13.5 66.6 ± 11.4 .03
Twelve months
Liters 1.99 ± 0.63 1.95 ± 0.49 .8
% of std. 100.2 ± 25.0 96.5 ± 21.1 .5
% of pre. 93.3 ± 10.3 87.3 ± 14.0 .03
FVC, Forced vital capacity; FEV1, 1-second forced expiratory volume; % of
std., the ratio of actual volume to the standard volume; % of pre., the ratio of
postoperative volume to preoperative volume. The distribution is represented
by the mean value ± standard deviation.
Table IV. Multiple linear regression analysis for
determinants of postoperative pulmonary function
Variables Coefficient ± SD 95% CI P value
FVC at 12 months 
(% of standard)
Preoperative FVC 0.9 ± 0.1 (0.7, 1.1) <.01
(% of standard)
Segmentectomy 3.9 ± 2.8 (–1.7, 9.5) .2
(vs lobectomy)
Upper lobe 6.4 ± 3.0 (0.5, 12.3) .03
(vs lower lobe)
Intercept 7.2 ± 9.9 (–12.5, 27.0) .5
FEV1 at 12 months 
(% of standard)
Preoperative FEV1 0.9 ± 0.1 (0.7, 1.0) <.01
(% of standard)
Segmentectomy 8.0 ± 3.1 (1.9, 14.1) .01
(vs lobectomy)
Upper lobe 7.4 ± 3.2 (1.0, 13.7) .03
(vs lower lobe)
Intercept 12.2 ± 7.8 (–3.2, 27.7) .12
FVC, Forced vital capacity; FEV1, 1-second forced expiratory volume; SD,
standard deviation; CI, confidence interval.
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tive FVC was associated with an increase in the post-
operative FVC of 0.9% ± 0.1%. The 95% confidence
interval (CI) ranged from 0.7% to 1.1%. The alternative
surgical procedure of segmentectomy or lobectomy did
not significantly influence the postoperative FVC. The
postoperative FVC for patients with right or left upper
lobe surgery was 6.4% ± 3.0% higher than that for
those with right or left lower lobe surgery. The 95% CI
ranged from 0.5% to 12.3%. An increase in 1% in the
preoperative FEV1 was associated with an increase in
the postoperative FEV1 of 0.9% ± 0.1%. The 95% CI
ranged from 0.7% to 1.0%. Patients who had under-
gone segmentectomies had 8.0% ± 3.1% higher FEV1
after the operation than those who had undergone
lobectomies. The 95% CI ranged from 1.9% to 14.1%.
The postoperative FEV1 for patients with right or left
upper lobe surgery was 7.4% ± 3.2% higher than that
for patients with right or left lower lobe surgery. The
95% CI ranged from 1.0% to 13.7%.
Discussion
In this study, the operative procedure was not chosen
randomly. The alternative of segmentectomy or lobec-
tomy was left to the discretion of the surgeon. As
shown in Table II, the resected segments in the seg-
mentectomy group were not uniformly distributed over
the lung. When a tumor was localized at the apical seg-
ment in the right or left lower lobe, a segmentectomy
was probably performed. When a tumor was at the pos-
terior basal segment, a lobectomy was likely done. Our
surgeons expected to observe functional benefit after
apical segmentectomy, but not after posterior basal seg-
mentectomy, which was considered to be a difficult
surgical procedure. Unless a wedge resection, as well
as a segmentectomy, is accepted as a procedure for lim-
ited resection, it is difficult to perform a randomized
trial of lobectomy versus limited resection for small
peripheral lung cancer. We had a nonrandomized con-
trol group. For bias reduction in the comparison of a
nonrandomized control group, we paired the segmen-
tectomy group with the lobectomy group using the
nearest available matching method on the propensity
score. We believe that the bias has been reduced
enough to allow postoperative pulmonary function to
be compared between the 2 groups.
The results of this study suggest that a good-risk
patient will not obtain a great functional benefit if seg-
mentectomy is performed in place of lobectomy for a
small peripheral lung cancer. Some lobar segments that
are removed by a lobectomy are not removed by seg-
mental resection of a tumor. Segmentectomy apparent-
ly has an anatomic advantage over lobectomy. Why is
the functional benefit of segmentectomy slight com-
pared with the anatomic advantage over lobectomy?
Ali and colleagues14 found a disproportionate early
loss, followed by significant functional improvement
with time after lobectomy. Zeiher and coworkers11
demonstrated the predicted postoperative FEV1, which
is based on the number of remaining segments, to con-
sistently underestimate the actual postoperative FEV1
by approximately 250 mL. The lobectomy group in this
study showed significant functional improvement that
was more than predicted. The lobectomy group in a
randomized trial had a postoperative/preoperative
FEV1 ratio that is very similar to ours.5 The significant
functional improvement after lobectomy has been
demonstrated repeatedly. The remaining postoperative
function is thus more than anticipated on the basis of
the remaining tissue in most patients who underwent a
lobectomy. This is the reason that the functional bene-
fit by segmentectomy is slight compared with the
anatomic advantage over lobectomy.
Despite our careful intraoperative nodal assessment,
we could not exclude 6 patients with nodal metastasis
from our candidates for segmentectomy. Five of the 6
patients had adenocarcinomas of the lung. Adeno-
carcinoma has a considerable potential for lymph node
metastasis; even small adenocarcinomas measuring 2
cm or less in diameter do.15-19 An intraoperative assess-
ment is not reliable for identifying lymph node metasta-
sis in small peripheral adenocarcinoma of the lung.19
Patients who undergo a lesser resection run the risk of
microscopic tumor cells being left in either lobar or seg-
mental lymph nodes. A randomized study demonstrated
that patients who undergo lesser resections have a high-
er risk of local recurrence than those who undergo a
lobectomy.5 Segmentectomy should not be performed
in place of lobectomy for good-risk patients with a
small peripheral tumor because of the difficulty of iden-
tifying metastatic lymph nodes during the operation.
Who benefits from segmentectomy? Patients with
limited FEV1 may benefit if they need as great a post-
operative FEV1 as possible. Who loses? Patients with
metastatic lymph nodes lose. Our patients with
metastatic lymph nodes who underwent segmentec-
tomies were subjected to completion lobectomy, irradi-
ation, or the risk of a local recurrence developing, prob-
lems that might have been obviated had they undergone
lobectomy.
We excluded poor-risk patients category and patients
with secondary lung cancer from this study. However,
we do not believe that the results of this study rule out
the usefulness of lesser resections in such patients.
In conclusion, pulmonary function after a segmen-
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tectomy for a good-risk patient is slightly better than
that after a lobectomy. However, segmentectomy
should still be the surgical procedure for only poor-risk
patients because of the difficulty in excluding patients
with metastatic lobar disease from the candidates for
the procedure.
We thank Associate Professor Kazuo Endoh for his statisti-
cal support, Mrs Youko Minagawa for her physiologic assis-
tance, and Mr Brian Quinn for his critical review.
R E F E R E N C E S
1. Martini N, Bains MS, Burt ME, et al. Incidence of local recur-
rence and second primary tumors in resected stage I lung cancer.
J Thorac Cardiovasc Surg 1995;109:120-9. 
2. Warren WH, Faber LP. Segmentectomy versus lobectomy in
patients with stage I pulmonary carcinoma: five-year survival and
patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg
1994;107:1087-94.
3. Landreneau RJ, Sugarbaker DJ, Mack MJ, et al. Wedge resection
versus lobectomy for stage I (T1 N0 M0) non–small-cell lung
cancer. J Thorac Cardiovasc Surg 1997;113:691-700.
4. Kodama K, Doi O, Higashiyama M, Yokouchi H. Intentional lim-
ited resection for selected patients with T1 N0 M0 non–small-cell
lung cancer: a single-institution study. J Thorac Cardiovasc Surg
1997;114:347-53.
5. Lung Cancer Study Group. Randomized trial of lobectomy ver-
sus limited resection for T1N0 non-small cell lung cancer. Ann
Thorac Surg 1995;60:615-23.
6. Tubota N, Ayabe K, Doi O, et al. Ongoing prospective study of
segmentectomy for small lung tumors. Ann Thorac Surg 1998;
66:1787-90.
7. Takizawa T, Terashima M, Koike T, Akamatsu H, Kurita Y,
Yokoyama A. Mediastinal lymph node metastasis in patients with
clinical stage I peripheral non–small-cell lung cancer. J Thorac
Cardiovasc Surg 1997;113:248-52.
8. American Thoracic Society. Standardization of spirometry—
1987 update. Am Rev Respir Dis 1987;136:1285-98.
9. Baldwin D, Cournand A, Richards D Jr. Pulmonary insufficiency.
I. Physiological classification, clinical methods of analysis, stan-
dard values in normal subjects. Medicine 1948;27:243-78.
10. Berglund E, Birath G, Bjure J, et al. Spirometric studies in nor-
mal subjects. I. Forced expirograms in subjects between 7 and 70
years of ages. Acta Med Scand 1963;173:185-92.
11. Zeiher BG, Gross TJ, Kern JA, Lanza LA, Peterson MW. Pre-
dicting postoperative pulmonary function in patients undergoing
lung resection. Chest 1995;108:68-72.
12. D’Agostino RB Jr. Propensity score methods for bias reduction in
the comparison of a non-randomized control group. Stat Med
1998;17:2265-81.
13. Glenn W, Baue A, Geha A, Hammond G, Laks H. Thoracic and
cardiovascular surgery. 4th ed. East Norwalk: Appleton-Century-
Crofts; 1983. 
14. Ali MK, Mountain CF, Ewer MS, Johnston D, Haynie TP.
Predicting loss of pulmonary function after resection for bron-
chogenic carcinoma. Chest 1980;77:337-42.
15. Takise A, Kodama T, Shimosato Y, Watanabe S, Suemasu K.
Histopathological prognostic factors in adenocarcinomas of the
peripheral lung less than 2 cm in diameter. Cancer 1988;61:2083-8.
16. Asamura H, Nakamura H, Kondo H, Tsuchiya R, Naruke T.
Lymph node involvement, recurrence, and prognosis in resected
peripheral, non–small-cell lung carcinomas: Are these carcino-
mas candidates for video-assisted lobectomy? J Thorac
Cardiovasc Surg 1996;111:1125-34.
17. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarci-
noma of the lung. Cancer 1995;75:2844-52.
18. Ichinose Y, Yano T, Asoh H, Yokoyama H, Yoshino I, Katsuda Y.
Prognostic factors obtained by a pathologic examination in com-
pletely resected non–small-cell lung cancer: an analysis in each
pathologic stage. J Thorac Cardiovasc Surg 1995;110:601-5.
19. Takizawa T, Terashima M, Koike T, et al. Lymph node metastasis
in small peripheral adenocarcinoma of the lung. J Thorac Cardio-
vasc Surg 1998;116:276-80.
